South San Francisco, CA, United States of America

Qingping Tian

This inventor holds 10 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 4 EPO patents. Top assignees: Genentech, Inc., Agouron Pharmaceuticals, Inc., Sumitomo Chemical Company, Limited. Active years: 2002-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Qingping Tian. Retrieved from https://idiyas.com/inventor/qingping-tian

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 (Patent Applications = 1)

% Patents Active = 70.0

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 4 (Patent Applications = 6)

Average Co-Inventor Count = 8.4

ph-index = 3

Forward Citations = 27(Granted Patents)

Location History:

San Diego, CA (US) (2002 - 2007)
Palo Alto, CA (US) (2013 - 2014)
South San Francisco, CA (US) (2013 - 2023)

Company Filing History:

Agouron Pharmaceuticals, Inc.

patents

1 out of 6,961

Sumitomo Chemical Company, Limited

patents

where one patent can have more than one assignee

Years Active: 2002-2023

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11661424 - Process for preparing BTK inhibitors (2023-05-30),

2. 10882864 - Process for preparing BTK inhibitors (2021-01-05),

3. 10385058 - Process for preparing BTK inhibitors (2019-08-20),

4. 8895729 - Process for making thienopyrimidine compounds (2014-11-25),

5. 8785651 - Method for manufacturing a boronic acid ester compound (2014-07-22),

6. 8431694 - Process for making thienopyrimidine compounds (2013-04-30),

7. 8354528 - Process for making thienopyrimidine compounds (2013-01-15),

8. 7232910 - Methods of preparing indazole compounds (2007-06-19),

9. 6774243 - Efficient synthetic routes for the preparation of rhinovirus protease inhibitors and key intermediates (2004-08-10),

10. 6355807 - Efficient synthetic routes for the preparation of rhinovirus protease inhibitors and key intermediates (2002-03-12),

Title: Qingping Tian: Innovator in BTK Inhibitors

Introduction

Qingping Tian is a prominent inventor based in South San Francisco, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of Bruton's Tyrosine Kinase (BTK) inhibitors. With a total of 10 patents to his name, Tian's work has had a substantial impact on medical research and drug development.

Latest Patents

Among his latest patents, Tian has developed methods for preparing BTK inhibitors. One notable patent details the process for preparing the compound 2-{3'-hydroxymethyl-1-methyl-5-[5-((S)-2-methyl-4-oxetan-3-yl-piperazin-1-yl)-pyridin-2-ylamino]-6-oxo-1,6-dihydro-[3,4′]bipyridinyl-2′-yl}-7,7-dimethyl-3,4,7,8-tetrahydro-2H,6H-cyclopenta[4,5]pyrrolo[1,2-a]pyrazin-1-one. Additionally, he has provided methods for preparing tricyclic lactam compounds, further showcasing his innovative approach to pharmaceutical chemistry.

Career Highlights

Tian has worked with notable companies in the pharmaceutical industry, including Genentech, Inc. and Agouron Pharmaceuticals, Inc. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in drug development.

Collaborations

Throughout his career, Qingping Tian has collaborated with esteemed colleagues such as Srinivasan Babu and Zhigang Cheng. These partnerships have facilitated the exchange of ideas and fostered advancements in their shared field of expertise.

Conclusion

Qingping Tian's contributions to the development of BTK inhibitors and his extensive patent portfolio highlight his role as an influential inventor in the pharmaceutical industry. His work continues to pave the way for innovative treatments and advancements in medical research.

Profile summary based on public USPTO records.